Looker, Helen C.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010

Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 621

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 432

Gestational Glucose Tolerance and Risk of Type 2 Diabetes in Young Pima Indian Offspring

Franks, P. W., Looker, H. C., Kobes, S., Touger, L., Tataranni, P. A., Hanson, R. L., & Knowler, W. C. (2006) · Diabetes

Gestational Diabetes Research and ManagementBirth, Development, and Health

Cited by 253

Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium

Shin, J.-I., Chang, A. R., Grams, M. E., Coresh, J., Ballew, S. H., Surapaneni, A., Matsushita, K., Bilo, H. J. G., Carrero, J. J., Chodick, G., et al. (2021) · Hypertension

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 155

Changes in BMI and Weight Before and After the Development of Type 2 Diabetes

Looker, H. C., Knowler, W. C., & Hanson, R. L. (2001) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 136

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening Programme

on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., et al. (2013) · Diabetologia

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 80

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes

on behalf of the SUMMIT Investigators, Looker, H. C., Colombo, M., Agakov, F., Zeller, T., Groop, L., Thorand, B., Palmer, C. N., Hamsten, A., de Faire, U., et al. (2015) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 66

Progression of diabetes retinal status within community screening programs and potential implications for screening intervals

Leese, G. P., Stratton, I. M., Land, M., Bachmann, M. O., Jones, C., Scanlon, P., Looker, H. C., & Ferguson, B. (2015) · Diabetes Care

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 50